Logo image of CELG

CELGENE CORP (CELG) Stock Price, Quote, News and Overview

NASDAQ:CELG - Nasdaq -

108.24  +0.11 (+0.1%)

After market: 109.4 +1.16 (+1.07%)

CELG Quote, Performance and Key Statistics

CELGENE CORP

NASDAQ:CELG (11/20/2019, 8:00:00 PM)

After market: 109.4 +1.16 (+1.07%)

108.24

+0.11 (+0.1%)

Sector
GICS SectorN/A
GICS IndustryN/A
GICS IndustryGroupN/A
GICS SubIndustryN/A
Statistics
52 Week High110.7
52 Week Low58.59
Market Cap77.04B
Shares711.71M
Float604.93M
Yearly Dividend0
Dividend Yield0%
PE11
Fwd PE9.14
Earnings (Next)N/A N/A
IPON/A N/A


CELG short term performance overview.The bars show the price performance of CELG in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10 15

CELG long term performance overview.The bars show the price performance of CELG in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60

The current stock price of CELG is 108.24 null. In the past month the price increased by 3.1%. In the past year, price increased by 62.4%.

CELGENE CORP / CELG Daily stock chart

About CELG

Company Profile

Celgene Corporation is a global biopharmaceutical company engaged in the discovery, development and commercialization of innovative therapies for the treatment of cancer and immune-inflammatory related diseases. Their portfolio of commercial products include REVLIMID, VIDAZA, THALOMID, POMALYST/IMNOVID, ABRAXANE, OTEZLA, ISTODAX and IDHIFA. The drug candidates in their pipeline are at various stages of preclinical and clinical development. These candidates include their IMiDs compounds, which are a proprietary class of compounds that have certain immunomodulatory and other biologically important properties in addition to their leading oral anti-inflammatory agents and cellular therapies. They believe their commercial stage products and the depth of their product pipeline, provide the catalysts for future growth.

Company Info

CELGENE CORP

86 MORRIS AVENUE

SUMMIT NJ 07901

CEO: Mark J. Alles

Phone: 908-673-9000

CELGENE CORP / CELG FAQ

What is the stock price of CELGENE CORP today?

The current stock price of CELG is 108.24 null. The price increased by 0.1% in the last trading session.


What is the ticker symbol for CELGENE CORP stock?

The exchange symbol of CELGENE CORP is CELG and it is listed on the Nasdaq exchange.


On which exchange is CELG stock listed?

CELG stock is listed on the Nasdaq exchange.


What is CELGENE CORP worth?

CELGENE CORP (CELG) has a market capitalization of 77.04B null. This makes CELG a Large Cap stock.


What are the support and resistance levels for CELGENE CORP (CELG) stock?

CELGENE CORP (CELG) has a support level at 103.73 and a resistance level at 109.42. Check the full technical report for a detailed analysis of CELG support and resistance levels.


Should I buy CELGENE CORP (CELG) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does CELGENE CORP (CELG) stock pay dividends?

CELG does not pay a dividend.


What is the Price/Earnings (PE) ratio of CELGENE CORP (CELG)?

The PE ratio for CELGENE CORP (CELG) is 11. This is based on the reported non-GAAP earnings per share of 9.84 and the current share price of 108.24 null. Check the full fundamental report for a full analysis of the valuation metrics for CELG.


CELG Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to CELG. When comparing the yearly performance of all stocks, CELG is one of the better performing stocks in the market, outperforming 94.89% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CELG Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to CELG. While CELG belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CELG Financial Highlights

Over the last trailing twelve months CELG reported a non-GAAP Earnings per Share(EPS) of 9.84. The EPS increased by 33.51% compared to the year before.


Industry RankSector Rank
PM (TTM) 34.62%
ROA 14.22%
ROE 48.65%
Debt/Equity 1.51
Chartmill High Growth Momentum
EPS Q2Q%35.47%
Sales Q2Q%16.14%
EPS 1Y (TTM)33.51%
Revenue 1Y (TTM)15.29%

CELG Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 60% to CELG. The Buy consensus is the average rating of analysts ratings from 17 analysts.


Ownership
Inst Owners0.01%
Ins Owners0.21%
Short Float %N/A
Short RatioN/A
Analysts
Analysts60
Price TargetN/A
EPS Next Y40.6%
Revenue Next YearN/A